Developing a new therapeutic approach for the treatment of tumor metastasis.

Founded in 2019 in Barcelona, as a spin off from the IRB and ICREA, Ona is developing a new therapeutic approach for the treatment of tumor metastasis based on the inhibition of the receptor CD36.

Fund

Alta Life Sciences Spain I FCR

Sector

Therapeutics

Exit year